US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 0.3572
  • -0.0260-6.78%
Close May 6 16:00 ET
  • 0.3570
  • -0.0002-0.06%
Post 20:01 ET
11.86MMarket Cap-0.13P/E (TTM)

Relmada Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-53.38%44.91M
-53.38%44.91M
-49.07%54.12M
-40.57%70.44M
-36.87%83.61M
-35.06%96.32M
-35.06%96.32M
-42.29%106.27M
-44.08%118.53M
-39.98%132.44M
-Cash and cash equivalents
-5.73%3.86M
-5.73%3.86M
-77.85%1.48M
-85.58%2.09M
-95.38%1.34M
-24.17%4.09M
-24.17%4.09M
-84.25%6.7M
-61.17%14.47M
-35.70%28.89M
-Short-term investments
-55.49%41.05M
-55.49%41.05M
-47.14%52.63M
-34.32%68.35M
-20.54%82.28M
-35.47%92.23M
-35.47%92.23M
-29.70%99.57M
-40.43%104.06M
-41.07%103.55M
Receivables
----
----
----
----
----
----
----
--0
--0
--0
Prepaid assets
-25.20%886.46K
-25.20%886.46K
-44.08%1.58M
-84.53%537.52K
-75.65%752.33K
-70.63%1.19M
-70.63%1.19M
-4.05%2.83M
-0.26%3.47M
-69.05%3.09M
Other current assets
----
----
----
----
----
----
----
-5.13%37
----
----
Total current assets
-53.03%45.8M
-53.03%45.8M
-48.94%55.7M
-41.83%70.97M
-37.75%84.37M
-36.21%97.51M
-36.21%97.51M
-41.69%109.1M
-43.45%122M
-39.97%135.53M
Non current assets
Other non current assets
-49.04%21.98K
-49.04%21.98K
-53.95%21.98K
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
Total non current assets
-49.04%21.98K
-49.04%21.98K
-53.95%21.98K
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
Total assets
-53.03%45.82M
-53.03%45.82M
-48.95%55.72M
-41.80%71.03M
-37.74%84.41M
-36.20%97.55M
-36.20%97.55M
-41.67%109.15M
-43.44%122.04M
-39.96%135.57M
Liabilities
Current liabilities
Payables
17.81%4.13M
17.81%4.13M
-17.89%2.35M
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
-accounts payable
17.81%4.13M
17.81%4.13M
-17.89%2.35M
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
Current accrued expenses
-11.92%5.01M
-11.92%5.01M
6.64%4.38M
-25.70%4.35M
14.45%6.5M
-8.10%5.68M
-8.10%5.68M
-51.85%4.1M
-41.68%5.85M
48.84%5.68M
Other current liabilities
400.00%27
400.00%27
158.82%20
---20
----
-121.95%-9
-121.95%-9
-383.33%-34
----
----
Current liabilities
-15.61%10.29M
-15.61%10.29M
-3.98%8.09M
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
Non current liabilities
Employee benefits
--4.47K
--4.47K
----
----
----
--0
--0
----
----
----
Other non current liabilities
----
----
--12.56K
----
----
----
----
----
----
----
Total non current liabilities
--4.47K
--4.47K
--12.56K
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-15.57%10.3M
-15.57%10.3M
-3.83%8.1M
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
Shareholders'equity
Share capital
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
-common stock
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-14.26%-640.88M
-14.26%-640.88M
-16.14%-622.22M
-16.89%-600.5M
-19.31%-582.73M
-21.38%-560.9M
-21.38%-560.9M
-26.30%-535.74M
-33.53%-513.74M
-41.65%-488.43M
Paid-in capital
4.66%676.37M
4.66%676.37M
5.25%669.82M
5.91%661.96M
6.66%654.75M
7.26%646.23M
7.26%646.23M
7.78%636.43M
7.47%625.04M
10.57%613.87M
Total stockholders'equity
-58.38%35.52M
-58.38%35.52M
-52.72%47.63M
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
Total equity
-58.38%35.52M
-58.38%35.52M
-52.72%47.63M
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -53.38%44.91M-53.38%44.91M-49.07%54.12M-40.57%70.44M-36.87%83.61M-35.06%96.32M-35.06%96.32M-42.29%106.27M-44.08%118.53M-39.98%132.44M
-Cash and cash equivalents -5.73%3.86M-5.73%3.86M-77.85%1.48M-85.58%2.09M-95.38%1.34M-24.17%4.09M-24.17%4.09M-84.25%6.7M-61.17%14.47M-35.70%28.89M
-Short-term investments -55.49%41.05M-55.49%41.05M-47.14%52.63M-34.32%68.35M-20.54%82.28M-35.47%92.23M-35.47%92.23M-29.70%99.57M-40.43%104.06M-41.07%103.55M
Receivables ------------------------------0--0--0
Prepaid assets -25.20%886.46K-25.20%886.46K-44.08%1.58M-84.53%537.52K-75.65%752.33K-70.63%1.19M-70.63%1.19M-4.05%2.83M-0.26%3.47M-69.05%3.09M
Other current assets -----------------------------5.13%37--------
Total current assets -53.03%45.8M-53.03%45.8M-48.94%55.7M-41.83%70.97M-37.75%84.37M-36.21%97.51M-36.21%97.51M-41.69%109.1M-43.45%122M-39.97%135.53M
Non current assets
Other non current assets -49.04%21.98K-49.04%21.98K-53.95%21.98K55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K
Total non current assets -49.04%21.98K-49.04%21.98K-53.95%21.98K55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K
Total assets -53.03%45.82M-53.03%45.82M-48.95%55.72M-41.80%71.03M-37.74%84.41M-36.20%97.55M-36.20%97.55M-41.67%109.15M-43.44%122.04M-39.96%135.57M
Liabilities
Current liabilities
Payables 17.81%4.13M17.81%4.13M-17.89%2.35M-13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M
-accounts payable 17.81%4.13M17.81%4.13M-17.89%2.35M-13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M
Current accrued expenses -11.92%5.01M-11.92%5.01M6.64%4.38M-25.70%4.35M14.45%6.5M-8.10%5.68M-8.10%5.68M-51.85%4.1M-41.68%5.85M48.84%5.68M
Other current liabilities 400.00%27400.00%27158.82%20---20-----121.95%-9-121.95%-9-383.33%-34--------
Current liabilities -15.61%10.29M-15.61%10.29M-3.98%8.09M-10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M
Non current liabilities
Employee benefits --4.47K--4.47K--------------0--0------------
Other non current liabilities ----------12.56K----------------------------
Total non current liabilities --4.47K--4.47K--12.56K--0--0--0--0--0--0--0
Total liabilities -15.57%10.3M-15.57%10.3M-3.83%8.1M-10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M
Shareholders'equity
Share capital 0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K
-common stock 0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -14.26%-640.88M-14.26%-640.88M-16.14%-622.22M-16.89%-600.5M-19.31%-582.73M-21.38%-560.9M-21.38%-560.9M-26.30%-535.74M-33.53%-513.74M-41.65%-488.43M
Paid-in capital 4.66%676.37M4.66%676.37M5.25%669.82M5.91%661.96M6.66%654.75M7.26%646.23M7.26%646.23M7.78%636.43M7.47%625.04M10.57%613.87M
Total stockholders'equity -58.38%35.52M-58.38%35.52M-52.72%47.63M-44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M
Total equity -58.38%35.52M-58.38%35.52M-52.72%47.63M-44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.